SCHEMBL24506563

SCHEMBL24506563

CC(C)(C)c1cc(N)c2cnc(N)nc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ HRH4 Q9H3N8 2/20 0.39
▸ HRH3 Q9Y5N1 2/20 0.39
▸ LCK P06239 2/20 0.35
▸ KDR P35968 2/20 0.35
▸ KIT P10721 1/20 0.35
▸ SRC P12931 1/20 0.35
▸ POLB P06746 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ RECQL P46063 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ NUDT1 P36639 3/20 0.34
▸ DHFR P00374 3/20 0.33
▸ HSP90AA1 P07900 1/20 0.33
▸ CSNK1D P48730 1/20 0.33
▸ CSNK1E P49674 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24506591 0.75 KDM4E (0.38) GAAMAPTKDM4EHRH4HRH3
SCHEMBL24506569 0.74 GAA (0.39) GAAMAPTKDM4EPOLBMEN1
SCHEMBL22521626 0.74 CSNK1D (0.44) GAAMAPTKDM4EHRH4HRH3
SCHEMBL24506570 0.74 NR4A2 (0.41) GAAMAPTKDM4EHRH4HRH3
SCHEMBL179533 0.70 LCK (0.52) GAAMAPTHRH4HRH3LCK
SCHEMBL24506820 0.69 HSD17B10 (0.39) ALDH1A1NUDT1DHFR
SCHEMBL24506782 0.69 HSD17B10 (0.35) KDM4ESRCALOX5AP
SCHEMBL24506593 0.67 HRH4 (0.46) GAAMAPTHRH4HRH3MEN1
SCHEMBL14063677 0.67 HRH4 (0.56) HRH4HRH3DHFRNPC1RAB9A
SCHEMBL2054624 0.66 KDM4E (0.40) GAAMAPTKDM4EPOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212143-A9 PRMT5 INHIBITOR COMPOUNDS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2023-07-06 — — US disclosed
US-20230212143-A9 PRMT5 INHIBITOR COMPOUNDS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2023-07-06 — — US disclosed
US-20220185792-A1 PRMT5 INHIBITOR COMPOUNDS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2022-06-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220185792-A1 PRMT5 INHIBITOR COMPOUNDS PRMT5, PRMT1, PRMT6 GAA 3055/4885MAPT 1665/4885KDM4E 90/4885
US-20230212143-A9 PRMT5 INHIBITOR COMPOUNDS PRMT5, PRMT1, PRMT6 GAA 3055/4885MAPT 1665/4885KDM4E 90/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback